Medicines by Bausch + Lomb Ireland Limited – Spain
Filters
Clear filtersFilters
A
Arteoptic 1% colirio de liberacion prolongada
Dosage form: Prolonged‑release eye drops, 30.00 mg
Active substance: Carteolol hydrochloride
Manufacturer: Bausch + Lomb Ireland Limited
Prescription required
Arteoptic 2% colirio de liberacion prolongada
Dosage form: Prolonged‑release eye drops, 60.00 mg
Active substance: Carteolol hydrochloride
Manufacturer: Bausch + Lomb Ireland Limited
Prescription required
Arteoptic 20 mg/ml unidosis colirio de liberacion prolongada en envase unidosis
Dosage form: Prolonged‑release eye drops, 4 mg
Active substance: Carteolol hydrochloride
Manufacturer: Bausch + Lomb Ireland Limited
Prescription required
M
Minims fenilefrina hidrocloruro 100 mg/ml colirio en solucion
Dosage form: Eye drops, solution, 100 mg/ml
Active substance: Phenylephrine hydrochloride
Manufacturer: Bausch + Lomb Ireland Limited
Prescription required
Minims fluoresceina sodica 20 mg/ml colirio en solucion
Dosage form: Eye drops, solution, 20 ml
Active substance: Fluorescein sodium
Manufacturer: Bausch + Lomb Ireland Limited
Prescription required
Minims tropicamida 10 mg/ml colirio en solucion en envase unidosis
Dosage form: Eye drops, solution, 5 mg
Active substance: Tropicamide
Manufacturer: Bausch + Lomb Ireland Limited
Prescription required
V
Vividrin 0,5 mg/ml colirio en solucion en envase unidosis
Dosage form: Eye drops, solution in single‑dose container, 0.5 mg/mL
Active substance: Azelastine hydrochloride
Manufacturer: Bausch + Lomb Ireland Limited
Prescription required
Vizibim 0,3 mg/ml colirio en solucion
Dosage form: Eye drops, solution, 0.30 mg
Active substance: Bimatoprost
Manufacturer: Bausch + Lomb Ireland Limited
Prescription required
Vizilatan 50 microgramos/ml colirio en solucion
Dosage form: Eye drops, solution, 50 micrograms/mL
Active substance: Latanoprost
Manufacturer: Bausch + Lomb Ireland Limited
Prescription required
Stay informed and save on care
Get health tips, platform updates, and exclusive promos for subscribers.
Follow us on social media
